Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancer

Cancer biology & therapy (2017) - Comment
pubmed: 28886275 doi: 10.1080/15384047.2017.1364323 issn: 1555-8576

Avital Lev, Safoora Deihimi, Elena Shagisultanova, Joanne Xiu, Amriti R Lulla, David T Dicker, Wafik S El-Deiry